Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Patient Information Leaflet last updated on the eMC: 10/05/2010
PIL Fuzeon 90 mg/ml powder and solvent for solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
Updated on 19/12/2008 and displayed until 10/05/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 21/07/2008 and displayed until 19/12/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/11/2007 and displayed until 21/07/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 07/11/2007 and displayed until 15/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 29/01/2007 and displayed until 07/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
Updated on 03/11/2006 and displayed until 29/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to storage instructions
Updated on 06/01/2006 and displayed until 03/11/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 13/04/2005 and displayed until 06/01/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to dosage and administration
  • Change to date of revision
Updated on 31/01/2005 and displayed until 13/04/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 06/07/2004 and displayed until 31/01/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to date of revision
Updated on 21/04/2004 and displayed until 06/07/2004
Reasons for adding or updating:
  • Change to Further Information section
  • Change to how to administer the medicine
  • Change to information about the device
Updated on 21/08/2003 and displayed until 21/04/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   enfuvirtide